Dr. Catherine Gordon named Chair of Pediatrics and Pediatrician-in-Chief of Texas Children's
Dear Members of the Baylor College of Medicine Community,
Mark A. Wallace, President & CEO of Texas Children’s, and I are pleased to announce that Dr. Catherine Gordon has been appointed the Chair of the Department of Pediatrics and Pediatrician-in-Chief of Texas Children’s Hospital. She will join Baylor and Texas Children’s on October 1.
Dr. Gordon is currently Professor of Pediatrics at Harvard Medical School and Chief of Adolescent Medicine at Boston Children's Hospital where she is also Director of the Boston Children’s DXA Center and Co-Director of the Center for Young Women’s Health. She is nationally and internationally recognized for her research on factors that affect bone health in adolescents and young adults.
For almost two decades, she has led an independently funded adolescent bone health research group with support from the NIH, the DOD and private foundations. She has authored numerous journal articles, books and book chapters on her research and on adolescent healthcare and serves as an associate editor for the journal, Bone, and the Journal of Adolescent Health. Dr. Gordon is also an outstanding educator and has focused on mentoring early clinical investigators and junior faculty into strong careers in clinical and translational research.
She received her medical degree from the University of North Carolina in 1991 and completed residency and fellowship training at Boston Children’s Hospital in 1998. She joined Harvard Medical School after completing her fellowship. Dr. Gordon has also held leadership positions at the Warren Alpert Medical School at Brown University where she was Vice Chair of Research in Pediatrics and at Cincinnati Children’s Hospital as Director of the Adolescent Division.
Please join me in welcoming Dr. Gordon to Baylor and Texas Children’s and in thanking Dr. Gordon Schutze, Interim Chair of the Department of Pediatrics, and Dr. James Versalovic, Interim Pediatrician-in-Chief, for their outstanding leadership during the search process.
Paul Klotman, M.D.
President & CEO